Merrimack Pharmaceuticals
MACK
#8766
Rank
NZ$0.40 B
Marketcap
NZ$27.60
Share price
0.00%
Change (1 day)
6.04%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): NZ$23.15

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$25.28. In 2016 the company made an earnings per share (EPS) of NZ-$22.31 an increase over its 2015 EPS that were of NZ-$24.08.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ$23.15
2016NZ-$22.31-7.35%
2015NZ-$24.0865%
2014NZ-$14.59-39.39%
2013NZ-$24.08-54.01%
2012NZ-$52.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$3.61-85.71%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
NZ-$0.15-100.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
NZ-$3.45-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
NZ-$1.53-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$53.43-311.33%๐Ÿ‡บ๐Ÿ‡ธ USA